Dylan Coronado
Pharmacogenomic testing for SSRIs analyzes CYP2C19 and CYP2D6 genes to predict how your body metabolizes antidepressants. This can prevent severe side effects by matching drug choice and dose to your genetics.
Jan 3 2026
Sep 28 2025
Oct 15 2025
Nov 28 2025
Oct 3 2025